Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Blood Pressure Volume 27, 2018 - Issue 3

Submit an article Journal homepage

Open access

2,628

Views

CrossRef citations to date

Altmetric

Original Article

A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension

Hiromi RakugiDepartment of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; View further author information

Kohei ShimizuTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanView further author information

Yuya NishiyamaTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanCorrespondence[email protected]
View further author information

Yuhei SanoTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanView further author information

Yuusuke UmedaTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanView further author information

Pages 125-133 | Received 08 Aug 2017, Accepted 30 Nov 2017, Published online: 13 Dec 2017

Cite this article
https://doi.org/10.1080/08037051.2017.1412797
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Supplemental material

Online_Supplement.docx

Download MS Word (14.6 KB)

Related Research Data

A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension

Source: Figshare

Linking provided by

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references